Atreca, Inc. Soared
Fri, Mar 04, 2022 at 05:30 PM
Atreca, Inc. (BCEL:NASDAQ) jumped higher at $5.2, a gain of 211.4%. The stock got featured on our News Catalysts scanner on Fri, Mar 04, 2022 at 09:59 AM in the 'MISCELLANEOUS' category. From Fri, Feb 18, 2022, the stock recorded 50.00% Up Days and 55.56% Green Days
The share price of the company has been moving sideways in recent weeks.
About Atreca, Inc. (BCEL:NASDAQ)
Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.
Top 10 Gainers:
- Atreca, Inc. (BCEL:NASDAQ), 211.38%
- Indonesia Energy Corporation Limited (INDO:NYSEMKT), 101.83%
- Keyarch Acquisition Corporation (KYCH:NASDAQ), 100%
- Mexco Energy Corporation (MXC:NYSEMKT), 84.47%
- Imperial Petroleum Inc. (IMPP:NASDAQ), 53.64%
- VEON Ltd. (VEON:NASDAQ), 52.09%
- ION Geophysical Corporation (IO:NYSE), 49.42%
- Nine Energy Service, Inc. (NINE:NYSE), 42.86%
- Origin Agritech Limited (SEED:NASDAQ), 35.21%
- E-Home Household Service Holdings Limited (EJH:NASDAQ), 33.12%